Skip to main content

Advertisement

Table 2 Comorbidities

From: The impact of multimorbidity on foot health outcomes in podiatry patients with musculoskeletal foot pain: a prospective observational study

Condition, n (%) Diagnosed with condition Receiving treatment for condition Condition limits activities
Heart disease 12 (10.4) 10 (8.7) 6 (5.2)
High blood pressure 23 (20) 18 (15.7) 6 (5.2)
Lung disease 11 (9.6) 8 (7.0) 4 (3.5)
Diabetes 7 (6.1) 4 (3.5) 3 (2.6)
Ulcer/stomach disease 13 (11.3) 11 (9.6) 6 (5.2)
Kidney disease 3 (2.6) 1 (0.9) 2 (1.7)
Liver disease 3 (2.6) 1 (0.9) 1 (0.9)
Anaemia or other blood disease 10 (8.7) 6 (5.2) 6 (5.2)
Cancer 6 (5.2) 2 (1.7) 2 (1.7)
Depression 20 (17.4) 11 (9.6) 15 (13.0)
Osteoarthritis or degenerative arthritis 38 (33.0) 24 (20.9) 32 (27.8)
Back Pain 50 (43.5) 22 (19.1) 34 (29.6)
Rheumatoid or inflammatory arthritis 9 (7.8) 5 (4.3) 6 (5.2)
Other medical problems 44 (38.3)
 Rheumatic or musculoskeletal diseasesa 7 (6.1)
 Neurological conditionsb 9 (7.9)
 Hypo/hyper thyroidism 5 (4.4)
 Asthma 4 (3.5)
 Sleep apnoea 3 (2.6)
 Other 16 (13.9)
  1. agout, mixed connective tissue disease, Sjogren’s syndrome, ankylosing spondylitis, fibromyalgia, osteopenia, and benign hypermobility (all n = 1)
  2. bstroke/transient ischaemic attack (n = 3), trigeminal neuralgia, multiple sclerosis, Parkinson’s disease, epilepsy, polio, and neuropathy (all n = 1)
  3. N Number of participants